Executive Summary:
This notification, issued by the Ministry of Health and Family Welfare, regulates the manufacture, sale, and distribution of Oseltamivir Phosphate and Zanamivir. It supersedes notification G.S.R. 677E, dated September 15, 2009, and implements recommendations from the Drugs Technical Advisory Board. The notification comes into force on the date of its publication in the Official Gazette, February 17, 2017.
Key Points / Main Content:
* **Manufacture and Distribution:**
* Requires prior written approval from the Drugs Controller General India for manufacture for sale or distribution.
* **Application of Rules:**
* Conditions specified in the Drugs and Cosmetics Rules, 1945, for Schedule H1 drugs apply to Oseltamivir Phosphate and Zanamivir.
* **Export:**
* The Drugs Controller General India may allow export of the drugs with recorded reasons in writing and in consultation with the Central Government.
* **Monthly Statements:**
* Manufacturers must submit a monthly statement to the Drugs Controller General India detailing the quantity of drugs supplied to distributors, stockists, and dealers.
* Distributors, stockists, and dealers must submit a monthly statement to the concerned licensing authority in the State or Union territory, detailing the quantity of drugs available with them.
Impact Analysis:
Manufacturers of Oseltamivir Phosphate and Zanamivir
* *Impact:* Subject to stricter regulations regarding manufacturing, distribution, and reporting.
* *Action Required:* Obtain prior written approval for manufacture, comply with Schedule H1 conditions, submit monthly statements to the Drugs Controller General India.
Distributors, Stockists, and Dealers:
* *Impact:* Subject to new monthly reporting requirements.
* *Action Required:* Submit monthly statements to the concerned licensing authority regarding stock levels.
Drugs Controller General India:
* *Impact:* Responsible for granting manufacturing approvals, potentially allowing exports and receiving monthly statements from manufacturers.
* *Action Required:* Review and approve manufacturing requests, consider export requests, and process monthly statements from manufacturers.
Licensing Authorities (State/Union Territory):
* *Impact:* Receive monthly statements from distributors, stockists and dealers
* *Action Required:* Process monthly statements from distributors, stockists and dealers
Key Entities Referenced
Drugs and Cosmetics Act, 1940: A legislative act referenced for conferring powers related to drug regulation.
Ministry of Health and Family Welfare: The government ministry responsible for health and family welfare policies.
Oseltamivir Phosphate: A drug whose manufacture, sale, and distribution is being regulated.
Zanamivir: A drug whose manufacture, sale, and distribution is being regulated.
Drugs Technical Advisory Board: An advisory board that considered the issue of restriction of sale of drugs.
Schedule X: A schedule of drugs under the Drugs and Cosmetics Rules, 1945, to which Oseltamivir Phosphate and Zanamivir were initially considered to be similar.
Drugs and Cosmetics Rules, 1945: The rules under the Drugs and Cosmetics Act, 1940, that govern the regulation of drugs.
Schedule H1: A schedule of drugs under the Drugs and Cosmetics Rules, 1945, to which the sale of Oseltamivir Phosphate and Zanamivir is being aligned.
jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99
vlk/kj.k
EXTRAORDINARY
Hkkx II—[k.M 3—mi&[k.M (i)
PART II—Section 3—Sub-section (i)
izkf/dkj ls izdkf'kr
PUBLISHED BY AUTHORITY
la- 117] ubZ fnYyh] 'kqØokj] iQjojh 17] 2017@ek?k 28] 1938
No. 117] NEW DELHI, FRIDAY FEBRUARY 17, 2017/MAGHA 28, 1938
(cid:7021)वा(cid:7021)(cid:7005)य और प(cid:7407)रवार क(cid:7016)याण म(cid:7074)ं ालय
((cid:7021)वा(cid:7021)(cid:7005)य और प(cid:7407)रवार क(cid:7016)याण िवभाग)
अिधसचू ना
नई (cid:7408)द(cid:7016)ली, 17 फरवरी, 2017
सा.का.िन. 144(अ).—के(cid:7008)(cid:7076)ीय सरकार का यह समाधान हो गया था (cid:7408)क ‘ओसेलटािमवीर फासफेट’ और
‘जनिमवीर’ औषिधयां महामारी के कारण उ(cid:7004)प(cid:7382) होन े वाली आपातकालीन अपे(cid:6979)ा(cid:7312) को पूरा करन े के िलए लोक
िहत म(cid:7286) आव(cid:7019)यक थ(cid:7277) और उ(cid:7334) औषिधय(cid:7298) और उन पर आधा(cid:7407)रत िन(cid:7414)मितय(cid:7298) के द(cid:7271)ु पयोग के िनवारण के िलए उनके
िविनमा(cid:6981)ण, िव(cid:7059)य और िवतरण को िविनयिमत और िनब(cid:7304)िधत करना आव(cid:7019)यक और समीचीन था;
और के(cid:7008)(cid:7076)ीय सरकार ने औषिध और (cid:7079)साधन साम(cid:7061)ी अिधिनयम, 1940(1940 का 23) क(cid:7409) धारा 26ख
(cid:7367)ारा (cid:7079)द(cid:7275) शि(cid:7334)य(cid:7298) का (cid:7079)योग करते (cid:7263)ए, भारत के राजप(cid:7074), असाधारण, भाग II, खंड 3, उपखंड (i) म(cid:7286) (cid:7079)कािशत
अिधसूचना सं(cid:6990)यांक सा.का.िन. 677(अ), तारीख 15 िसत(cid:7013)बर, 2009 (cid:7367)ारा यह िनदशे (cid:7408)दया था (cid:7408)क कोई (cid:7390)ि(cid:7334)
‘ओसेलटािमवीर फासफेट’ और ‘जनिमवीर’ औषिध वाली (cid:7408)कसी िन(cid:7414)मित का, उ(cid:7334) अिधसूचना म(cid:7286) िविन(cid:7416)द(cid:7397) रीित के
िसवाय, िव(cid:7059)य या िवतरण के िलए िविनमा(cid:6981)ण नह(cid:7277) करेगा या उसका िव(cid:7059)य या (cid:7021)टाक नह(cid:7277) करेगा या िव(cid:7059)य के िलए
सं(cid:7079)द(cid:7414)शत या (cid:7079)(cid:7021)थािपत नह(cid:7277) करेगा या िवत(cid:7407)रत नह(cid:7277) करेगा;
और औषिध तकनीक(cid:7409) सलाहकार बोड (cid:6981) न े औषिध और (cid:7079)साधन साम(cid:7061)ी िनयम, 1945 क(cid:7409) अनुसूची भ म(cid:7286)
िन(cid:7416)द(cid:7397) औषिधय(cid:7298) के सम(cid:7272)प ‘ओसेलटािमवीर फासफेट’ और ‘जनिमवीर’ औषिधय(cid:7298) के िव(cid:7059)य को िनब(cid:7304)िधत करन े के
(cid:7079)(cid:7396) पर तारीख 15 नव(cid:7013)बर, 2016 को िवचार (cid:7408)कया और यह िसफा(cid:7407)रश क(cid:7409) (cid:7408)क तारीख 15 िसत(cid:7013)बर, 2009 क(cid:7409)
अिधसूचना सा. का. िन. 677(अ) वापस ले ली जाएगी और उ(cid:7334) औषिधय(cid:7298) को उ(cid:7334) िनयम(cid:7298) क(cid:7409) अनुसूची ज1 म (cid:7286)
िन(cid:7416)द(cid:7397) औषिधय(cid:7298) के समान िव(cid:7059)य के िलए अनु(cid:6980)ात (cid:7408)कया जाएगा;
अतः अब, के(cid:7008)(cid:7076)ीय सरकार, औषिध और (cid:7079)साधन साम(cid:7061)ी अिधिनयम, 1940(1940 का 23) क(cid:7409) धारा 26ख
(cid:7367)ारा (cid:7079)द(cid:7275) शि(cid:7334)य(cid:7298) का (cid:7079)योग करते (cid:7263)ए और औषिध तकनीक(cid:7409) सलाहकार बोड (cid:6981) क(cid:7409) िसफा(cid:7407)रश(cid:7298) के आधार पर और
917 GI/2017 (1)(cid:32)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)]
भारत के राजप(cid:7074), असाधारण, भाग II, खंड 3, उपखंड (i) म(cid:7286) (cid:7079)कािशत भारत सरकार के (cid:7021)वा(cid:7021)(cid:7005)य और प(cid:7407)रवार
क(cid:7016)याण मं(cid:7074)ालय ((cid:7021)वा(cid:7021)(cid:7005)य िवभाग) क(cid:7409) अिधसूचना सं(cid:6990)यांक 677(अ), तारीख 15 िसत(cid:7013)बर, 2009 को उन बात(cid:7298) के
िसवाय अिध(cid:7059)ातं करत े (cid:7263)ए, िज(cid:7008)ह (cid:7286) ऐस े अिध(cid:7059)मण स े पूव(cid:6981) (cid:7408)कया गया ह ै या करने का लोप (cid:7408)कया गया ह,ै यह िनदशे
दते ी ह ै (cid:7408)क कोई (cid:7390)ि(cid:7334) ‘ओसले टािमवीर फासफेट’ और ‘जनिमवीर’ औषिध वाली (cid:7408)कसी िन(cid:7414)मित का, िन(cid:7388)िलिखत
रीित के िसवाय, िव(cid:7059)य या िवतरण के िलए िविनमा(cid:6981)ण नह(cid:7277) करेगा या उसका िव(cid:7059)य या (cid:7021)टाक नह(cid:7277) करेगा या िव(cid:7059)य
के िलए सं(cid:7079)द(cid:7414)शत या (cid:7079)(cid:7021)थािपत नह(cid:7277) करेगा या िवत(cid:7407)रत नह(cid:7277) करेगा, अथात(cid:6981) ;्
(क) कोई (cid:7390)ि(cid:7334) (cid:7021)वयं या अपनी ओर से (cid:7408)कसी अ(cid:7008)य (cid:7390)ि(cid:7334) (cid:7367)ारा औषध िनयं(cid:7074)क (भारत) के िलिखत पूव(cid:6981)
अनुमोदन के िबना िव(cid:7059)य या िवतरण के िलए िविनमा(cid:6981)ण नह(cid:7277) करेगा;
(ख) उ(cid:7334) अिधिनयम के अधीन बनाए गए औषिध और (cid:7079)साधन साम(cid:7061)ी िनयम, 1945 म(cid:7286) उन िनयम(cid:7298) क(cid:7409)
अनुसूची ज1 म (cid:7286) िविन(cid:7416)द(cid:7397) औषिधय(cid:7298) क(cid:7409) बाबत िविन(cid:7416)द(cid:7397) शत(cid:7288) ‘ओसेलटािमवीर फासफेट’ और ‘जनिमवीर’
औषिधय(cid:7298) या उन पर आधा(cid:7407)रत (cid:7408)कसी िन(cid:7414)मित को लागू ह(cid:7298)गी:
पर(cid:7008)तु औषध िनयं(cid:7074)क(भारत) ‘ओसेलटािमवीर फासफेट’ और ‘जनिमवीर’ औषिध या उन पर आधा(cid:7407)रत
(cid:7408)कसी िविन(cid:7414)मित का िनया(cid:6981)त, उन कारण(cid:7298) से, जो लेखब(cid:7373) (cid:7408)कए जाए ं और के(cid:7008)(cid:7076)ीय सरकार के परामश(cid:6981) स े
अनु(cid:6980)ात कर सकेगा;
(ग) ‘ओसेलटािमवीर फासफेट’ और ‘जनिमवीर’ औषिध या उन पर आधा(cid:7407)रत (cid:7408)कसी िविन(cid:7414)मित का (cid:7079)(cid:7004)येक
िविनमा(cid:6981)ता, औषध िनयं(cid:7074)क (भारत) को एक ऐसी मािसक िववरणी (cid:7079)(cid:7021)तुत करेगा, िजसम(cid:7286) उनके (cid:7367)ारा
िवतरक(cid:7298), (cid:7021)टा(cid:7408)क(cid:7021)ट(cid:7298), (cid:7390)वहा(cid:7407)रय(cid:7298) को (cid:7079)(cid:7004)येक मास के अंत तक (cid:7079)दाय क(cid:7409) गई ऐसी औषिधय(cid:7298) क(cid:7409) मा(cid:7074)ा
अंत(cid:7414)व(cid:7397) हो ।
(घ) ऐसा (cid:7079)(cid:7004)येक िवतरक, (cid:7021)टा(cid:7408)क(cid:7021)ट और (cid:7390)वहारी, जो ‘ओसेलटािमवीर फासफेट’ और ‘जनिमवीर’ औषिध
या उन पर आधा(cid:7407)रत (cid:7408)कसी िविन(cid:7414)मित का (cid:7021)टाक रखता ह,ै यथाि(cid:7021)थित, रा(cid:6996)य या संघ-रा(cid:6996)य(cid:6979)े(cid:7074) म(cid:7286) संबंिधत
अनु(cid:6980)ापन (cid:7079)ािधकारी को ऐसी मािसक िववरणी (cid:7079)(cid:7021)ततु करेगा, िजसम(cid:7286) (cid:7079)(cid:7004)येक मास के अंत तक उनके पास
उपल(cid:7011)ध ऐसी ओषिधय(cid:7298) क(cid:7409) मा(cid:7074)ा अंत(cid:7414)व(cid:7397) हो;
2. यह अिधसूचना राजप(cid:7074) म(cid:7286) इसके (cid:7079)काशन क(cid:7409) तारीख से (cid:7079)वृ(cid:7275) होगी ।
[फा. सं. ए(cid:6989)स.11014/10/2016-डी.आर.एस.]
कु(cid:7008)दन लाल शमा(cid:6981),संयु(cid:7334) सिचव
(cid:7407)ट(cid:7009)पण: मूल अिधसूचना, भारत के राजप(cid:7074), असाधारण, भाग II, खंड 3, उपखंड (i) म(cid:7286) अिधसूचना सं(cid:6990)यांक सा.
का.िन. 677(अ), तारीख 15 िसत(cid:7013)बर, 2009 (cid:7367)ारा (cid:7079)कािशत क(cid:7409) गई थी ।
MINISTRY OF HEALTH AND FAMILY WELFARE
(Department of Health and Family Welfare)
NOTIFICATION
New Delhi, the 17th February, 2017
G.S.R. 144(E).—Whereas the Central Government was satisfied that the drugs ‘Oseltamivir Phosphate’ and
‘Zanamivir’ were essential to meet the requirements of emergency arising due to epidemic and in public interest, and it
was necessary and expedient to regulate and restrict the manufacture, sale and distribution of the said drugs and
preparations based thereon for preventing their misuse;¹Hkkx IIµ[k.M 3(i)º Hkkjr dk jkti=k % vlk/kj.k 3
And Whereas the Central Government in exercise of the powers conferred by section 26B of the Drugs and
Cosmetics Act, 1940 (23 of 1940), (cid:118)(cid:100)(cid:105)(cid:101) notification published in the Gazette of India, Extraordinary, Part II, Section 3,
Sub-section (i), number G.S.R. 677(E), dated the 15th September, 2009, directed that no person shall manufacture for sale
or distribution, or sell or stock, or exhibit or offer for sale, or distribute any preparation containing the drug ‘Oseltamivir
Phosphate’ or ‘Zanamivir’ except in the manner specified in the said notification;
And Whereas, the Drugs Technical Advisory Board considered the issue of restriction of sale of the drugs
‘Oseltamivir Phosphate’ and ‘Zanamivir’ similar to the drugs referred to in the Schedule X of the Drugs and Cosmetics
Rules, 1945 on 15th November, 2016 and recommended that the notification G.S.R. 677(E), dated the 15th September,
2009 shall be withdrawn and the said drugs be permitted for sale similar to the drugs referred to in the Schedule H1 of
the said rules;
Now, therefore, in exercise of the powers conferred by section 26B of the Drugs and Cosmetics Act, 1940 (23 of
1940) and on the basis of the recommendations of the Drugs Technical Advisory Board, the Central Government hereby
and in supersession of the notification of the Government of India, Ministry of Health and Family Welfare (Department
of Health) published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R. 677(E)
dated the 15th September, 2009 except as respects things done or omitted to be done before such supersession directs that
no person shall manufacture for sale or for distribution or sale or stock or exhibit or offer for sale or distribute any
preparation containing the drug ‘Oseltamivir Phosphate’ or ‘Zanamivir’ except in the following manner, namely:-
(a)(cid:32) no person shall himself or by any other person on his behalf manufacture for sale or for distribution without the
prior approval in writing from the Drugs Controller General (India).
(b)(cid:32) the conditions specified in the Drugs and Cosmetics Rules, 1945 in respect of the drugs specified under
Schedule H1 to that rules shall apply to the drugs ‘Oseltamivir Phosphate’ and ‘Zanamivir‘ or any preparation
based thereon.
Provided that the Drugs Controller General (India) may allow export of the drug ‘Oseltamivir Phosphate’ and
‘Zanamivir’ or any preparation based thereon for reasons to be recorded in writing and in consultation with the
Central Government.
(c)(cid:32) every manufacturer of the drug ‘Oseltamivir Phosphate’ and ‘Zanamivir’ or any preparation based thereon shall
submit to the Drugs Controller General (India) a monthly statement, containing therein the quantity of such
drugs supplied by them to distributors, stockists, dealers by the end of every month.
(d)(cid:32) every distributor, stockist and dealer holding stocks of ‘Oseltamivir Phosphate’ and ‘Zanamivir’ or any
preparation based thereon shall submit to the concerned licensing authority in the State or Union territory, as
the case may be, a monthly statement, containing therein the quantity of such drugs available with them, by the
end of every month.
2. This notification shall come into force on the date of its publication in the Official Gazette.
[F.No. X.11014/10/2016-DRS]
K. L. SHARMA, Jt. Secy.
Note: The principal notification was published in the Official Gazette, Extraordinary, Part II, Section 3, Sub-section (i)
(cid:118)(cid:100)(cid:105)(cid:101) notification number G.S.R. 677(E) dated the 15th September, 2009.
(cid:32)
(cid:32)
(cid:32)
(cid:32)
(cid:32)
(cid:32)
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.